Tech Company Financing Transactions
Allegro Diagnostics Funding Round
Catalyst Health Ventures and Kodiak Venture Partners participated in a $5.4 million Series A venture round for Allegro Diagnostics. The round closed on 7/7/2011.
Transaction Overview
Company Name
Announced On
7/7/2011
Transaction Type
Venture Equity
Amount
$5,400,000
Round
Series A
Investors
Catalyst Health Ventures (Josh Phillips)
Kodiak Venture Partners (Andrey Zarur)
Proceeds Purpose
Proceeds from the financing will support the commercialization of Allegro's lead genomic test, BronchoGen, in 2012.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6 Clock Tower Pl. 225
Maynard, MA 01754
USA
Maynard, MA 01754
USA
Phone
Website
Email Address
Overview
Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Webb
Chief Financial Officer
Bill Johnson
VP - R & D
Duncan Whitney
Browse more venture capital transactions:
Prev: 7/7/2011: Finsphere venture capital transaction
Next: 7/8/2011: Kickanotch venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs